POLOCAINE Drug Patent Profile

Which patents cover Polocaine, and what generic alternatives are available?

Polocaine is a drug marketed by Dentsply Pharm and Fresenius Kabi Usa and is included in seven NDAs.

The generic ingredient in POLOCAINE is levonordefrin; mepivacaine hydrochloride. There are two drug master file entries for this compound. Additional details are available on the levonordefrin; mepivacaine hydrochloride profile page.

Summary for POLOCAINE

US Patents:	0
Applicants:	2
NDAs:	7
Finished Product Suppliers / Packagers:	2
Raw Ingredient (Bulk) Api Vendors:	100
Patent Applications:	4,362
Drug Prices:	Drug price information for POLOCAINE
DailyMed Link:	POLOCAINE at DailyMed

See drug prices for POLOCAINE

Pharmacology for POLOCAINE

Drug Class	Amide Local Anesthetic
Physiological Effect	Local Anesthesia

US Patents and Regulatory Information for POLOCAINE

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Dentsply Pharm	POLOCAINE	mepivacaine hydrochloride	INJECTABLE;INJECTION	088653-001	Aug 21, 1984		DISCN	No	No
Fresenius Kabi Usa	POLOCAINE-MPF	mepivacaine hydrochloride	INJECTABLE;INJECTION	089409-001	Dec 1, 1986		RX	No	Yes
Dentsply Pharm	POLOCAINE W/ LEVONORDEFRIN	levonordefrin; mepivacaine hydrochloride	INJECTABLE;INJECTION	089517-001	Apr 14, 1988		DISCN	No	No
Fresenius Kabi Usa	POLOCAINE	mepivacaine hydrochloride	INJECTABLE;INJECTION	089407-001	Dec 1, 1986		RX	No	Yes
Fresenius Kabi Usa	POLOCAINE	mepivacaine hydrochloride	INJECTABLE;INJECTION	089410-001	Dec 1, 1986		RX	No	Yes
Fresenius Kabi Usa	POLOCAINE-MPF	mepivacaine hydrochloride	INJECTABLE;INJECTION	089408-001	Dec 1, 1986		RX	No	Yes
Fresenius Kabi Usa	POLOCAINE-MPF	mepivacaine hydrochloride	INJECTABLE;INJECTION	089406-001	Dec 1, 1986		RX	No	Yes